Onyx Biotec Limited (NSE:ONYX)

Onyx Biotec Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Operating Revenue	619.51	537.49	394.82	448.61
Other Revenue	11.67	-	0.1	-
Revenue	631.19	537.49	394.92	448.61
Revenue Growth (YoY)	17.43%	36.10%	-11.97%	-
Cost of Revenue	391.31	367.28	221.33	279.1
Gross Profit	239.87	170.21	173.59	169.51
Selling, General & Admin	86.45	60.13	105.03	86.56
Other Operating Expenses	38.32	26.96	23.1	25.69
Operating Expenses	155.24	109.59	143.05	126.72
Operating Income	84.64	60.62	30.54	42.79
Interest Expense	-19.86	-21.07	-5.65	-5.15
Interest & Investment Income	-	0.75	0.65	0.1
Currency Exchange Gain (Loss)	-	-	-0.01	-0
Other Non Operating Income (Expenses)	-0	0.21	0.01	0.26
EBT Excluding Unusual Items	64.78	40.52	25.54	38
Gain (Loss) on Sale of Assets	-	-	-0.07	-0.05
Pretax Income	64.78	40.52	25.47	37.95
Income Tax Expense	15.24	10.2	7.02	4.42
Net Income	49.54	30.32	18.45	33.53
Net Income to Common	49.54	30.32	18.45	33.53
Net Income Growth	63.42%	64.35%	-44.98%	-
Shares Outstanding (Basic)	15	12	12	12
Shares Outstanding (Diluted)	15	12	12	12
Shares Change (YoY)	25.78%	1.13%	-	-
EPS (Basic)	3.30	2.54	1.56	2.84
EPS (Diluted)	3.30	2.54	1.56	2.84
EPS Growth	29.93%	62.81%	-45.07%	-
Free Cash Flow	3.62	-17.07	-165.01	-53
Free Cash Flow Per Share	0.24	-1.43	-13.98	-4.49
Gross Margin	38.00%	31.67%	43.95%	37.79%
Operating Margin	13.41%	11.28%	7.73%	9.54%
Profit Margin	7.85%	5.64%	4.67%	7.47%
Free Cash Flow Margin	0.57%	-3.17%	-41.78%	-11.82%
EBITDA	115.11	83.12	45.45	57.27
EBITDA Margin	18.24%	15.46%	11.51%	12.77%
D&A For EBITDA	30.47	22.49	14.91	14.48
EBIT	84.64	60.62	30.54	42.79
EBIT Margin	13.41%	11.28%	7.73%	9.54%
Effective Tax Rate	23.52%	25.18%	27.57%	11.66%
Revenue as Reported	631.19	538.74	396.17	449.81
Advertising Expenses	-	0.06	0.09	0.03

Source: S&P Global Market Intelligence. Standard template. Financial Sources.